PRLR and invasive ductal breast carcinoma: Indeed, the co-expression between PRLR and both TGFβ receptors was found to be reduced by around 50% in invasive ductal carcinoma cases that are characterized by LN involvement compared with cases with no LN involvement (from ~30% to 15%).